 BELGRADE, Mont., Dec. 07, 2020 GLOBE NEWSWIRE -- Xtant Medical Holdings, Inc. NYSE American: XTNT, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the subscription period for its previously announced rights offering of shares of the Companys common stock at a subscription price of 1.07 per share expired on December 4, 2020, and these rights are no longer exercisable. 